AINDEX
Markets

CareDx, Inc. (CDNA)

CDNANASDAQ-GMMedical Specialities

$85.47

+6.91 (+8.79%) today

Closed, Nov 9, 4:00 PM ET

+8.79% 1D
Market cap
$4.44bn
P/E
129.5
EPS, last 4 quarters
$0.6600
Dividend yield
–
Day range
–
52-week range
$14.72 to $90.87
Average volume
1.37m
Previous close
$78.56

Analysts

4 covering

Buy2 buy, 2 hold, 0 sell

Targets a year out average $90.00, +5.3% from here

$81.00now $85.47$99.00

Earnings

next estimate $0.1300

Next report

Dec 2025

–

Mar 2026

+145.4%

Jun 2026

+183.3%

Sep 2026

+642.9%

estimate reported, and the surprise

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue$108.39m$117.70m$131.95m$139.36m
Gross profit$72.87m$84.07m$96.98m$99.08m
Operating income-$6.04m$1.20m$113.22m$8.11m
Net income-$4.11m$2.81m$110.64m$19.29m

Last four quarters: revenue $497.40m, margin 25.9%, free cash flow $59.76m

News

8 latest

The company

CareDx is a leading precision medicine diagnostics company advancing care in transplant, specialty oncology, and cell therapy. Through non-invasive longitudinal molecular biomarker testing, digital health, and patient support solutions, CareDx is dedicated to improving patient outcomes.

Sector
Health Care
Industry
Medical Specialities
Exchange
NASDAQ-GM
Region
North America
Website
caredx.com

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.

CareDx, Inc. (CDNA) price, chart and news · AINDEX